Create a narrative

Zydus Lifesciences Community

NSEI:ZYDUSLIFE Community

1 Narratives written by author
0 Comments on narratives written by author
20 Fair Values set on narratives written by author

Zydus Lifesciences

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 30 Analysts

Expansion Into Europe And Novel Treatments Will Boost Future Prospects, Yet Competition May Pressure Margins

Key Takeaways Strong growth in U.S. Formulations and Chronic segment could boost revenue and margins with market share expansion in key therapies. Focus on emerging markets, European expansions, and innovation pipeline may drive robust revenue growth and profitability through market exclusivity and competitive advantages.

₹970.10

FV

1.5% undervalued

4.75%

Revenue growth p.a.

0

0

9

4 days ago